S&P 500   3,852.36
DOW   32,920.46
QQQ   293.34
Mullen Automotive: The Good News, The Bad And The Ugly Outlook 
The Next Big Crisis Is Here (Ad)
A Non-Salesy Annuity Guide To Buying Annuities
3 Small Caps That Have Big Upside
Is This The End of Capitalism? (Ad)
Levi Strauss Is A Good Fit For Income Investors 
What Does Apple's Move to India Mean for Investors?
Is This The End of Capitalism? (Ad)
Mergers and Acquisitions in 2023 Off To A Strong Start
Chevron Delights Shareholders with $75 Billion in Share Buybacks
S&P 500   3,852.36
DOW   32,920.46
QQQ   293.34
Mullen Automotive: The Good News, The Bad And The Ugly Outlook 
The Next Big Crisis Is Here (Ad)
A Non-Salesy Annuity Guide To Buying Annuities
3 Small Caps That Have Big Upside
Is This The End of Capitalism? (Ad)
Levi Strauss Is A Good Fit For Income Investors 
What Does Apple's Move to India Mean for Investors?
Is This The End of Capitalism? (Ad)
Mergers and Acquisitions in 2023 Off To A Strong Start
Chevron Delights Shareholders with $75 Billion in Share Buybacks
S&P 500   3,852.36
DOW   32,920.46
QQQ   293.34
Mullen Automotive: The Good News, The Bad And The Ugly Outlook 
The Next Big Crisis Is Here (Ad)
A Non-Salesy Annuity Guide To Buying Annuities
3 Small Caps That Have Big Upside
Is This The End of Capitalism? (Ad)
Levi Strauss Is A Good Fit For Income Investors 
What Does Apple's Move to India Mean for Investors?
Is This The End of Capitalism? (Ad)
Mergers and Acquisitions in 2023 Off To A Strong Start
Chevron Delights Shareholders with $75 Billion in Share Buybacks
S&P 500   3,852.36
DOW   32,920.46
QQQ   293.34
Mullen Automotive: The Good News, The Bad And The Ugly Outlook 
The Next Big Crisis Is Here (Ad)
A Non-Salesy Annuity Guide To Buying Annuities
3 Small Caps That Have Big Upside
Is This The End of Capitalism? (Ad)
Levi Strauss Is A Good Fit For Income Investors 
What Does Apple's Move to India Mean for Investors?
Is This The End of Capitalism? (Ad)
Mergers and Acquisitions in 2023 Off To A Strong Start
Chevron Delights Shareholders with $75 Billion in Share Buybacks
NASDAQ:ATRI

Atrion - ATRI Stock Forecast, Price & News

$638.60
+11.10 (+1.77%)
(As of 01/26/2023 12:00 AM ET)
Add
Compare
Today's Range
$638.60
▼
$638.60
50-Day Range
$551.10
▼
$679.00
52-Week Range
$534.99
▼
$783.80
Volume
899 shs
Average Volume
4,235 shs
Market Capitalization
$1.13 billion
P/E Ratio
33.00
Dividend Yield
1.37%
Price Target
N/A

Atrion MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
2.70% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
N/A
News Sentiment
0.77mentions of Atrion in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.38 out of 5 stars

Medical Sector

81st out of 1,048 stocks

Surgical & Medical Instruments Industry

6th out of 104 stocks

See Top Rated MarketRank™ Stocks Here

ATRI stock logo

About Atrion (NASDAQ:ATRI) Stock

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Receive ATRI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Atrion and its competitors with MarketBeat's FREE daily newsletter.

ATRI Stock News Headlines

January 20, 2023 | msn.com
Snead State Community College and government officials break ground on new workforce skills training center
January 19, 2023 | americanbankingnews.com
Atrion (NASDAQ:ATRI) Trading 7.9% Higher
January 27, 2023 | Porter & Company (Ad)
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
January 16, 2023 | marketwatch.com
Contact Lenses Cases Market 2023 : SWOT Analysis by Players Continues Explosive Growth by 2029
January 13, 2023 | marketwatch.com
Inflation Devices Market 2023 Size Industry, Current Trends, Demand and Size Share Estimation by 2025 with Top Players MarketGrowthReports.com
January 11, 2023 | marketwatch.com
Contact Lenses Accessories Market 2023 : Growth Statistics, Industry Share, Latest Trends, Growth Drivers, Size and Forecast till 2028
December 17, 2022 | finance.yahoo.com
Atrion Corporation (ATRI) Stock Historical Prices & Data - Yahoo Finance
December 8, 2022 | seekingalpha.com
Atrion: Fair And Reasonably Priced For Resiliency Premium
January 27, 2023 | Porter & Company (Ad)
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
November 30, 2022 | finance.yahoo.com
Returns On Capital Signal Tricky Times Ahead For Atrion (NASDAQ:ATRI)
November 10, 2022 | finance.yahoo.com
Atrion Third Quarter 2022 Earnings: EPS: US$4.95 (vs US$4.59 in 3Q 2021)
November 8, 2022 | finance.yahoo.com
Atrion Reports Third Quarter 2022 Results
October 19, 2022 | finance.yahoo.com
Declining Stock and Decent Financials: Is The Market Wrong About Atrion Corporation (NASDAQ:ATRI)?
October 3, 2022 | finance.yahoo.com
Plurilock's Aurora Systems Receives US$2.8 Million 3-year Purchase Order from a U.S. Food, Facilities, and Uniform Services Provider
September 27, 2022 | proactiveinvestors.com
Plurilock Security earns repeat ‘Buy’ rating from broker Leede Jones Gable after closing of Atrion Communications asset acquisition
September 26, 2022 | finance.yahoo.com
Plurilock's Aurora Announces Closing of Asset Purchase Agreement with Atrion Communications, Inc.
September 15, 2022 | finance.yahoo.com
Atrion (NASDAQ:ATRI) investors are sitting on a loss of 21% if they invested three years ago
September 14, 2022 | nasdaq.com
Ex-Dividend Reminder: NorthWestern, Atrion and Merck
September 8, 2022 | seekingalpha.com
Atrion: Attractively Priced For Exposure To Defensive Healthcare
August 27, 2022 | marketwatch.com
Atrion Taps Cindy Ferguson to Serve as CFO Following Jeffery Strickland's Retirement
August 26, 2022 | finance.yahoo.com
Atrion's (NASDAQ:ATRI) Dividend Will Be Increased To $2.15
August 25, 2022 | finance.yahoo.com
Atrion Corporation Announces CFO Succession Plan
August 22, 2022 | marketwatch.com
Atrion Corp. Raises Dividend by 10%
August 22, 2022 | finance.yahoo.com
Atrion Corporation Increases Quarterly Cash Dividend by 10%
August 9, 2022 | reuters.com
ATRI.O - Atrion Corporation | Stock Price & Latest News | Reuters
August 9, 2022 | proactiveinvestors.com
Plurilock Security announces asset purchase agreement with Atrion Communications
August 9, 2022 | proactiveinvestors.com
Plurilock Security to acquire certain assets of cybersecurity solutions provider Atrion
See More Headlines
Receive ATRI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Atrion and its competitors with MarketBeat's FREE daily newsletter.

ATRI Company Calendar

Last Earnings
11/08/2022
Ex-Dividend for 12/15 Dividend
11/30/2022
Dividend Payable
12/15/2022
Today
1/26/2023
Next Earnings (Estimated)
2/24/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:ATRI
CUSIP
04990410
CIK
701288
Web
www.atrioncorp.com
Phone
(972) 390-9800
Fax
972-396-7581
Employees
667
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
$19.35
Trailing P/E Ratio
33.00
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$33.06 million
Net Margins
19.24%
Pretax Margin
22.36%
Return on Equity
14.16%
Return on Assets
12.82%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.42
Quick Ratio
4.09

Sales & Book Value

Annual Sales
$165.01 million
Price / Sales
6.86
Cash Flow
$25.18 per share
Price / Cash Flow
25.36
Book Value
$135.67 per share
Price / Book
4.71

Miscellaneous

Outstanding Shares
1,773,000
Free Float
1,371,000
Market Cap
$1.13 billion
Optionable
Not Optionable
Beta
0.30

Key Executives

  • Mr. Emile A. Battat (Age 85)
    Exec. Chairman
    Comp: $666.55k
  • Mr. David A. Battat (Age 53)
    Pres & CEO
    Comp: $1.94M
  • Mr. Jeffery Strickland (Age 64)
    CFO, VP, Treasurer & Sec.
    Comp: $986.38k
  • Ms. Cindy Ferguson
    Controller

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













ATRI Stock - Frequently Asked Questions

How have ATRI shares performed in 2023?

Atrion's stock was trading at $559.45 at the start of the year. Since then, ATRI stock has increased by 14.1% and is now trading at $638.60.
View the best growth stocks for 2023 here.

When is Atrion's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, February 24th 2023.
View our ATRI earnings forecast.

How were Atrion's earnings last quarter?

Atrion Co. (NASDAQ:ATRI) issued its earnings results on Tuesday, November, 8th. The medical instruments supplier reported $4.94 EPS for the quarter. The medical instruments supplier had revenue of $44.63 million for the quarter. Atrion had a net margin of 19.24% and a trailing twelve-month return on equity of 14.16%.

How often does Atrion pay dividends? What is the dividend yield for Atrion?

Atrion announced a quarterly dividend on Monday, November 14th. Stockholders of record on Thursday, December 1st will be paid a dividend of $2.15 per share on Thursday, December 15th. This represents a $8.60 annualized dividend and a dividend yield of 1.35%. The ex-dividend date of this dividend is Wednesday, November 30th.
Read our dividend analysis for ATRI.

Is Atrion a good dividend stock?

Atrion (NASDAQ:ATRI) pays an annual dividend of $8.60 per share and currently has a dividend yield of 1.37%. The company has been increasing its dividend for 19 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 44.44%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for ATRI.

What is David A. Batta's approval rating as Atrion's CEO?

1 employees have rated Atrion Chief Executive Officer David A. Batta on Glassdoor.com. David A. Batta has an approval rating of 100% among the company's employees. This puts David A. Batta in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 100.0% of employees surveyed would recommend working at Atrion to a friend.

What other stocks do shareholders of Atrion own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Atrion investors own include International Paper (IP), AT&T (T), WestRock (WRK), AbbVie (ABBV), Caterpillar (CAT), Eastman Chemical (EMN), Gilead Sciences (GILD), Altria Group (MO), Pfizer (PFE) and Philip Morris International (PM).

What is Atrion's stock symbol?

Atrion trades on the NASDAQ under the ticker symbol "ATRI."

Who are Atrion's major shareholders?

Atrion's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Boston Trust Walden Corp (1.74%), ICW Investment Advisors LLC (0.13%), Allspring Global Investments Holdings LLC (0.08%), Vestmark Advisory Solutions Inc. (0.07%), Strs Ohio (0.06%) and Exchange Traded Concepts LLC (0.04%). Insiders that own company stock include Emile A Battat and Jeffery Strickland.
View institutional ownership trends.

How do I buy shares of Atrion?

Shares of ATRI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Atrion's stock price today?

One share of ATRI stock can currently be purchased for approximately $638.60.

How much money does Atrion make?

Atrion (NASDAQ:ATRI) has a market capitalization of $1.13 billion and generates $165.01 million in revenue each year. The medical instruments supplier earns $33.06 million in net income (profit) each year or $19.35 on an earnings per share basis.

How many employees does Atrion have?

The company employs 667 workers across the globe.

How can I contact Atrion?

Atrion's mailing address is ONE ALLENTOWN PARKWAY, ALLEN TX, 75002. The official website for the company is www.atrioncorp.com. The medical instruments supplier can be reached via phone at (972) 390-9800, via email at ir-info@atrioncorp.com, or via fax at 972-396-7581.

This page (NASDAQ:ATRI) was last updated on 1/27/2023 by MarketBeat.com Staff